Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules.
Foschini F, Napolitano F, Servetto A, Marciano R, Mozzillo E, Carratù AC, Santaniello A, De Placido P, Cascetta P, Butturini G, Frigerio I, Regi P, Silvestris N, Delcuratolo S, Vasile E, Vivaldi C, Bianco C, De Placido S, Formisano L, Bianco R. Foschini F, et al. Among authors: mozzillo e. Ther Adv Med Oncol. 2020 Sep 29;12:1758835920947970. doi: 10.1177/1758835920947970. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33062062 Free PMC article.
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review.
Napolitano F, Formisano L, Giardino A, Girelli R, Servetto A, Santaniello A, Foschini F, Marciano R, Mozzillo E, Carratù AC, Cascetta P, De Placido P, De Placido S, Bianco R. Napolitano F, et al. Among authors: mozzillo e. Cancers (Basel). 2019 Jul 13;11(7):981. doi: 10.3390/cancers11070981. Cancers (Basel). 2019. PMID: 31337045 Free PMC article.
Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study.
Servetto A, Santaniello A, Napolitano F, Foschini F, Marciano R, Mozzillo E, Cascetta P, Amato AR, Augurio MR, Maresca L, De Placido P, De Placido S, Formisano L, Bianco R. Servetto A, et al. Among authors: mozzillo e. Cancers (Basel). 2021 Sep 30;13(19):4939. doi: 10.3390/cancers13194939. Cancers (Basel). 2021. PMID: 34638422 Free PMC article.
Factors influencing the acceptability of automated insulin delivery systems in youths with type 1 diabetes and their parents.
Franceschi R, Pertile R, Marigliano M, Mozzillo E, Maffeis C, Zaffani S, Dusini C, Antonelli A, Maltoni G, Candia FD, Cantarelli E, Minuto N, Bassi M, Rabbone I, Savastio S, Passanisi S, Lombardo F, Cherubini V, Saltarelli MA, Tumini S. Franceschi R, et al. Among authors: mozzillo e. Diabetes Res Clin Pract. 2025 Jan;219:111962. doi: 10.1016/j.diabres.2024.111962. Epub 2024 Dec 13. Diabetes Res Clin Pract. 2025. PMID: 39675483
Severe Obesity Defined by Percentiles of WHO and Cardiometabolic Risk in Youth with Obesity.
Valerio G, Di Bonito P, Di Sessa A, Ballarin G, Calcaterra V, Corica D, Faienza MF, Franco F, Licenziati MR, Maffeis C, Maltoni G, Miraglia Del Giudice E, Morandi A, Mozzillo E, Wasniewska M. Valerio G, et al. Among authors: mozzillo e. Children (Basel). 2024 Nov 1;11(11):1345. doi: 10.3390/children11111345. Children (Basel). 2024. PMID: 39594920 Free PMC article.
Sex-Related Differences in Cardiovascular Risk in Adolescents with Overweight or Obesity.
Di Bonito P, Di Sessa A, Licenziati MR, Corica D, Wasniewska M, Miraglia Del Giudice E, Morandi A, Maffeis C, Felicia Faienza M, Mozzillo E, Calcaterra V, Franco F, Maltoni G, Moio N, Iannuzzi A, Valerio G. Di Bonito P, et al. Among authors: mozzillo e. Rev Cardiovasc Med. 2024 Sep 29;25(10):353. doi: 10.31083/j.rcm2510353. eCollection 2024 Oct. Rev Cardiovasc Med. 2024. PMID: 39484121 Free PMC article. No abstract available.
Development and validation of a novel method for evaluation of multiple islet autoantibodies in dried blood spot using dissociation-enhanced lanthanide fluorescent immunoassays technology, specific and suitable for paediatric screening programmes.
Dufrusine B, Natale L, Sallese M, Mozzillo E, Di Candia F, Cuccurullo I, Iafusco D, Zanfardino A, Passariello L, Iannilli A, Santarelli S, Federici L, De Laurenzi V, Cherubini V, Pieragostino D. Dufrusine B, et al. Among authors: mozzillo e. Diabetes Obes Metab. 2025 Jan;27(1):414-418. doi: 10.1111/dom.16002. Epub 2024 Oct 21. Diabetes Obes Metab. 2025. PMID: 39429062 Free PMC article. No abstract available.
135 results